Acquisition of the facility expands Arclin’s footprint in North America, complementing the company’s existing treating operations in Tacoma, Washington and Cobourg, Ontario.

“The sale of the East Longmeadow treating facility to Arclin is a final step to return to our core competency of providing decorative surfaces and edgings to the North American market,” said Surteco North America CEO and president Michael Phillips.